Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine effects on autonomic modulation in bipolar depression
NCT01213121Phase 4Unknown
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Sep 2010
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of quetiapine (extended-release tablet, brand name: Bipresso) in bipolar disorder (BD), sponsored by Seoul National University Bundang Hospital. Status: unknown.
02
Drugs
quetiapine (extended-release tablet, brand name: Bipresso)
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT01213121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01213121.